Skip to content
2000
Volume 14, Issue 1
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Influenza is a disease that deeply affects millions of people every year. There has not been any drug effective against all strains. Neuraminidase (NA) is the major surface glycoprotein of the influenza virus, which possesses critical enzymatic activity and has been considered as a suitable target for designing agents against influenza viruses. Here we review the structure and functions of this enzyme and touch upon the structureactivity relationship (SAR) of existing influenza neuraminidase inhibitors (NAIs).

Loading

Article metrics loading...

/content/journals/cmc/10.2174/092986707779313444
2007-01-01
2025-05-21
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/092986707779313444
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test